Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)

Supporting evidence

• Review decision

• Review Decision – March 2016

• Appendix A - Review Decision Paper - March 2016  (PDF 84 KB)

  Published:

  03 March 2016